1. Home
  2. EPAC vs NVAX Comparison

EPAC vs NVAX Comparison

Compare EPAC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPAC
  • NVAX
  • Stock Information
  • Founded
  • EPAC 1910
  • NVAX 1987
  • Country
  • EPAC United States
  • NVAX United States
  • Employees
  • EPAC N/A
  • NVAX N/A
  • Industry
  • EPAC Industrial Machinery/Components
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EPAC Technology
  • NVAX Health Care
  • Exchange
  • EPAC Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • EPAC 2.4B
  • NVAX 2.0B
  • IPO Year
  • EPAC N/A
  • NVAX 1995
  • Fundamental
  • Price
  • EPAC $44.59
  • NVAX $9.76
  • Analyst Decision
  • EPAC Strong Buy
  • NVAX Buy
  • Analyst Count
  • EPAC 1
  • NVAX 6
  • Target Price
  • EPAC $35.00
  • NVAX $17.83
  • AVG Volume (30 Days)
  • EPAC 388.1K
  • NVAX 7.2M
  • Earning Date
  • EPAC 10-15-2024
  • NVAX 11-07-2024
  • Dividend Yield
  • EPAC 0.09%
  • NVAX N/A
  • EPS Growth
  • EPAC 91.76
  • NVAX N/A
  • EPS
  • EPAC 1.56
  • NVAX N/A
  • Revenue
  • EPAC $589,510,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • EPAC $10.55
  • NVAX N/A
  • Revenue Next Year
  • EPAC $5.46
  • NVAX N/A
  • P/E Ratio
  • EPAC $28.46
  • NVAX N/A
  • Revenue Growth
  • EPAC N/A
  • NVAX N/A
  • 52 Week Low
  • EPAC $27.06
  • NVAX $3.53
  • 52 Week High
  • EPAC $45.17
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • EPAC 63.60
  • NVAX 36.20
  • Support Level
  • EPAC $44.07
  • NVAX $9.52
  • Resistance Level
  • EPAC $45.17
  • NVAX $10.63
  • Average True Range (ATR)
  • EPAC 1.20
  • NVAX 0.57
  • MACD
  • EPAC 0.03
  • NVAX -0.12
  • Stochastic Oscillator
  • EPAC 91.78
  • NVAX 9.97

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group, previously known as Actuant, provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company operates through two segments: industrial tools and services and other. It categorizes its revenue into two parts: product sales and services, which include manpower services and rentals. Product sales is the largest contributor to the company's total revenue. Geographically, the company operates in the United States, Asia, Australia, Europe, Middle East, and other areas. The U.S. makes up the largest contribution to the company's total revenue.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: